These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 21871746)

  • 1. Fatal pulmonary thromboembolism. A retrospective autopsy study: searching for genetic thrombophilias (Factor V Leiden (G1691A) and FII (G20210A) gene variants) and dating the thrombus.
    Fineschi V; Bafunno V; Bello S; De Stefano F; Margaglione M; Neri M; Riezzo I; Turillazzi E; Bonsignore A; Vecchione G; Ventura F; Grandone E
    Forensic Sci Int; 2012 Jan; 214(1-3):152-8. PubMed ID: 21871746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.
    Emmerich J; Rosendaal FR; Cattaneo M; Margaglione M; De Stefano V; Cumming T; Arruda V; Hillarp A; Reny JL
    Thromb Haemost; 2001 Sep; 86(3):809-16. PubMed ID: 11583312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factor V Leiden (G1691A) and prothrombin gene G20210A mutations as potential risk factors for venous thromboembolism after total hip or total knee replacement surgery.
    Wåhlander K; Larson G; Lindahl TL; Andersson C; Frison L; Gustafsson D; Bylock A; Eriksson BI
    Thromb Haemost; 2002 Apr; 87(4):580-5. PubMed ID: 12008938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AB0 blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms.
    Miñano A; Ordóñez A; España F; González-Porras JR; Lecumberri R; Fontcuberta J; Llamas P; Marín F; Estellés A; Alberca I; Vicente V; Corral J
    Haematologica; 2008 May; 93(5):729-34. PubMed ID: 18387978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives.
    Aznar J; Vayá A; Estellés A; Mira Y; Seguí R; Villa P; Ferrando F; Falcó C; Corella D; España F
    Haematologica; 2000 Dec; 85(12):1271-6. PubMed ID: 11114134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factor V Leiden and prothrombin gene G20210A mutations in Italian patients with Behçet's disease and deep vein thrombosis.
    Silingardi M; Salvarani C; Boiardi L; Accardo P; Iorio A; Olivieri I; Cantini F; Salvi F; La Corte R; Triolo G; Ciccia F; Ghirarduzzi A; Filippini D; Paolazzi G; Iori I
    Arthritis Rheum; 2004 Apr; 51(2):177-83. PubMed ID: 15077257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation.
    De Stefano V; Martinelli I; Mannucci PM; Paciaroni K; Chiusolo P; Casorelli I; Rossi E; Leone G
    N Engl J Med; 1999 Sep; 341(11):801-6. PubMed ID: 10477778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of factor V Leiden and prothrombin G20210A mutation in a large French population selected for nonthrombotic history: geographical and age distribution.
    Mazoyer E; Ripoll L; Gueguen R; Tiret L; Collet JP; dit Sollier CB; Roussi J; Drouet L;
    Blood Coagul Fibrinolysis; 2009 Oct; 20(7):503-10. PubMed ID: 19730248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type and location of venous thromboembolism in carriers of Factor V Leiden or prothrombin G20210A mutation versus patients with no mutation.
    Kovac M; Mitic G; Mikovic Z; Antonijevic N; Djordjevic V; Mikovic D; Mandic V; Rakicevic L; Radojkovic D
    Clin Appl Thromb Hemost; 2010 Feb; 16(1):66-70. PubMed ID: 18796457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coexistence of factor V G1691A and factor II G20210A gene mutations in a thrombotic family is associated with recurrence and early onset of venous thrombosis.
    Gemmati D; Serino ML; Moratelli S; Tognazzo S; Ongaro A; Scapoli GL
    Haemostasis; 2001; 31(2):99-105. PubMed ID: 11684865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different circumstances of the first venous thromboembolism among younger or older heterozygous carriers of the G20210A polymorphism in the prothrombin gene.
    De Stefano V; Rossi E; Paciaroni K; D'Orazio A; Cina G; Marchitelli E; Pepe R; Leone G
    Haematologica; 2003 Jan; 88(1):61-6. PubMed ID: 12551828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of recurrent venous thrombosis in homozygous carriers and double heterozygous carriers of factor V Leiden and prothrombin G20210A.
    Lijfering WM; Middeldorp S; Veeger NJ; Hamulyák K; Prins MH; Büller HR; van der Meer J
    Circulation; 2010 Apr; 121(15):1706-12. PubMed ID: 20368522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interrelation of hyperhomocysteinemia and inherited risk factors for venous thromboembolism. Results from the E.D.I.TH. study: a hospital-based case-control study.
    Oger E; Lacut K; Le Gal G; Couturaud F; Abalain JH; Mercier B; Mottier D;
    Thromb Res; 2007; 120(2):207-14. PubMed ID: 17126889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor V Leiden G1691A and factor II G20210A point mutations and pregnancy in North-West of Iran.
    Bagheri M; Rad IA; Nanbakhsh F
    Arch Gynecol Obstet; 2011 Nov; 284(5):1311-5. PubMed ID: 21773779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of factor V gene G1691A, methylenetetrahydrofolate reductase gene C677T, and prothombin gene G20210A mutations on deep venous thrombogenesis in Behçet's disease.
    Toydemir PB; Elhan AH; Tükün A; Toydemir R; Gürler A; Tüzüner A; Bökesoy I
    J Rheumatol; 2000 Dec; 27(12):2849-54. PubMed ID: 11128675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for clinical manifestations in carriers of Factor V Leiden and prothrombin gene mutations.
    DeSancho MT; Berlus N; Christos PJ; Rand J
    Blood Coagul Fibrinolysis; 2010 Jan; 21(1):11-5. PubMed ID: 19474699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the risk of pulmonary embolism and deep vein thrombosis in the presence of factor V Leiden or prothrombin G20210A.
    Ordóñez AJ; Carreira JM; Alvarez CR; Rodríguez JM; Alvarez MV; Coto E
    Thromb Haemost; 2000 Feb; 83(2):352-4. PubMed ID: 10739402
    [No Abstract]   [Full Text] [Related]  

  • 18. The impact of heterozygosity for the factor V Leiden and factor II G20210A mutations on the risk of thrombosis in Greek patients.
    Hatzaki A; Anagnostopoulou E; Metaxa-Mariatou V; Melissinos C; Philalithis P; Iliadis K; Kontaxis A; Liberatos K; Pangratis N; Nasioulas G
    Int Angiol; 2003 Mar; 22(1):79-82. PubMed ID: 12771861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of factor V Leiden and G20210A prothrombin mutation on the presence of residual vein obstruction after idiopathic deep-vein thrombosis of the lower limbs.
    Cosmi B; Legnani C; Pengo V; Ghirarduzzi A; Testa S; Poli D; Prisco D; Tripodi A; Palareti G;
    Thromb Haemost; 2013 Mar; 109(3):510-6. PubMed ID: 23306310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium.
    Gerhardt A; Scharf RE; Beckmann MW; Struve S; Bender HG; Pillny M; Sandmann W; Zotz RB
    N Engl J Med; 2000 Feb; 342(6):374-80. PubMed ID: 10666427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.